Lewes, DE -- (SBWIRE) -- 07/29/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Creative Learning Corporation (OTCBB:CLCN), LabStyle Innovations Corp (OTCBB:DRIO), Brainstorm Cell Therapeutics Inc (OTCBB:BCLI), Insite Vision Inc. (OTCMKTS:INSV)
Creative Learning Corporation (OTCBB:CLCN) gained volume of 51,700 shares and the average volume of the stock remained 13,446shares. The 52 week range of the stock remained $0.49 - $1.62 and the day range was $1.40 - $1.62, recently. The stock opened the session at $1.45, and its recent trading price was $1.55. The stock showed a positive performance of 14.81% in its trading session. Creative Learning Corporation offers educational programs designed to teach principles of engineering, architecture, and physics to children under the Bricks 4 Kidz trade name. It provides LEGO, a line of construction toys, which include colorful interlocking plastic bricks and an accompanying array of gears, minifigures, and various other parts that can be assembled and connected in many ways to construct objects, such as vehicles, buildings, and working robots.
Will CLCN Continue To Move Higher? Find Out Here
In the recent trading session, LabStyle Innovations Corp (OTCBB:DRIO) traded 14,499 shares and the average volume of the stock remained 34,491 shares. The 52 week range of the stock remained $2.00 - $3.10. The stock was a bear and dropped -1.74%, while its trading price stayed at $2.83. The market capitalization of the stock remained 54.45 million. The half-yearly trend of the stock remained positive 13.65 %. LabStyle Innovations Corp. develops and commercializes a patent-pending technology that seeks to bring laboratory testing capabilities to consumers through the use of smartphones and other mobile devices. Its primary product is Dario, an easy-to-use medical device and software system for patient self-monitoring of blood glucose (SMBG) products.
Why Should Investors Buy DRIO After the Recent Fall? Just Go Here and Find Out
Brainstorm Cell Therapeutics Inc (OTCBB:BCLI) volume of the stock was 203,845 shares in the most recent session and the average volume remained 140,343 shares. The stock boosted 7.45% in its recent trading session, at the trading price of $0.215. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in developing adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Parkinson?s disease, and multiple sclerosis.
Why Should Investors Buy BCLI After The Recent Gain? Just Go Here and Find Out
Insite Vision Inc. (OTCMKTS:INSV) traded with volume of 214,562 shares and the average volume of the stock remained 204,539 shares. The stock decreased -7.67% and was recently trading at $0.175. The market capitalization of the stock remained 23.03 million. The beta of the stock remained 1.11. InSite Vision Incorporated, an ophthalmic product development company, develops ophthalmic pharmaceutical products to address unmet eye care needs based on its proprietary DuraSite drug delivery technology in the United States. It offers AzaSite and Besivance for the treatment of bacterial conjunctivitis (pink eye).
Will INSV Get Buyers Even After The Recent Rally? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/